| Patent | Date |
|---|
Pharmaceutical compositions containing peptides derived from human BPLP protein
Grant 9,714,951 - Rougeot , et al. July 25, 2 | 2017-07-25 |
Peptides Derived From Human Bplp Protein, Polynucleotides Coding For Said Peptides And Antibodies Directed Against Said Peptides
App 20160341744 - ROUGEOT; Catherine ; et al. | 2016-11-24 |
Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein
Grant 9,403,871 - Rougeot , et al. August 2, 2 | 2016-08-02 |
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
Grant 9,273,094 - Rougeot March 1, 2 | 2016-03-01 |
Opiorphin For Use As A Psychostimulant Agent
App 20150329608 - ROUGEOT; Catherine | 2015-11-19 |
Opiorphin Peptide Derivatives As Potent Inhibitors Of Enkephalin-degrading Ectopeptidases
App 20150065683 - ROUGEOT; Catherine | 2015-03-05 |
Peptides Derived From Human Bplp Protein, Polynucleotides Coding For Said Peptides And Antibodies Directed Against Said Peptides
App 20140349946 - ROUGEOT; Catherine ; et al. | 2014-11-27 |
Method for detecting human BPLP protein or a maturation product thereof
Grant 8,895,251 - Rougeot , et al. November 25, 2 | 2014-11-25 |
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
Grant 8,889,827 - Rougeot November 18, 2 | 2014-11-18 |
Use Of Basic Prolin-rich Lacrimal Gene Products, Such As Opiorphin, As A Biomarker
App 20140193843 - ROUGEOT; Catherine ; et al. | 2014-07-10 |
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
Grant 8,642,729 - Rougeot February 4, 2 | 2014-02-04 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
Grant 8,168,770 - Minoprio , et al. May 1, 2 | 2012-05-01 |
Use Of Basic Prolin-rich Lacrimal Gene Products, Such As Opiorphin, As A Biomarker
App 20120034604 - Rougeot; Catherine ; et al. | 2012-02-09 |
Peptides Derived From Human Bplp Protein, Polynucleotides Coding For Said Peptides And Antibodies Directed Against Said Peptides
App 20110244491 - ROUGEOT; Catherine ; et al. | 2011-10-06 |
Peptides derived from human BPLP protein
Grant 8,017,571 - Rougeot , et al. September 13, 2 | 2011-09-13 |
Opiorphin For Use As A Psychostimulant Agent
App 20110178021 - Rougeot; Catherine | 2011-07-21 |
Opiorphin Peptide Derivatives As Potent Inhibitors Of Enkephalin-degrading Ectopeptidases
App 20110124571 - Rougeot; Catherine | 2011-05-26 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
Grant 7,851,603 - Minoprio , et al. December 14, 2 | 2010-12-14 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
Grant 7,732,563 - Minoprio , et al. June 8, 2 | 2010-06-08 |
Process For Identifying A Ligand That Binds To The Nep Binding Site For The Smr1 Pentapeptide
App 20100041072 - Rougeot; Catherine ; et al. | 2010-02-18 |
Method For Identifying Bplp And Opiorphin Agonists Or Antagonists
App 20090298109 - Rougeot; Catherine | 2009-12-03 |
Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
Grant 7,625,713 - Rougeot , et al. December 1, 2 | 2009-12-01 |
Opiorphin Peptide Derivatives As Potent Inhibitors Of Enkephalin-degrading Ectopeptidases
App 20090253639 - ROUGEOT; Catherine | 2009-10-08 |
Therapeutic use of the SMR1 protein and active derivatives thereof
Grant 7,429,448 - Rougeot , et al. September 30, 2 | 2008-09-30 |
Treatment of mood disorders by administration of SMR1
Grant 7,423,020 - Rougeot , et al. September 9, 2 | 2008-09-09 |
Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides
App 20080206230 - Rougeot; Catherine ; et al. | 2008-08-28 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
Grant 7,387,778 - Marcel , et al. June 17, 2 | 2008-06-17 |
Therapeutic uses of SMR1 peptides
App 20070054861 - Rougeot; Catherine ; et al. | 2007-03-08 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20060292598 - Minoprio; Paolo ; et al. | 2006-12-28 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20060292596 - Minoprio; Paolo ; et al. | 2006-12-28 |
Therapeutic uses of SMR1 peptides
Grant 7,153,833 - Rougeot , et al. December 26, 2 | 2006-12-26 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20060252921 - Minoprio; Paola ; et al. | 2006-11-09 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20050130166 - Minoprio, Paola ; et al. | 2005-06-16 |
Cloning, sequencing and expresssion of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20050090656 - Minoprio, Paola ; et al. | 2005-04-28 |
Therapeutic use of the SMR1 protein and active derivatives thereof
Grant 6,818,405 - Rougeot , et al. November 16, 2 | 2004-11-16 |
Therapeutic uses of smri peptides
App 20040116342 - Rougeot, Catherine ; et al. | 2004-06-17 |
Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
App 20040092486 - Rougeot, Catherine ; et al. | 2004-05-13 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
Grant 6,713,617 - Minoprio , et al. March 30, 2 | 2004-03-30 |
Therapeutic use of the SMR1 protein and active derivatives thereof
App 20040047805 - Rougeot, Catherine ; et al. | 2004-03-11 |
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
App 20040018206 - Minoprio, Paola ; et al. | 2004-01-29 |
Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
App 20030195155 - Rougeot, Catherine ; et al. | 2003-10-16 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
App 20030186870 - Marcel, Tony ; et al. | 2003-10-02 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
App 20030078200 - Marcel, Tony ; et al. | 2003-04-24 |
Therapeutic Use Of The Smr 1 Protein And Active Derivatives Thereof
App 20020198361 - ROUGEOT, CATHERINE ; et al. | 2002-12-26 |
Therapeutic Use Of The Smr1 Protein, The Smr1 Maturation Products, Specifically The Qhnpr Pentapeptide As Well As Its Biologically Active Derivatives
App 20020019008 - ROUGEOT, CATHERINE ; et al. | 2002-02-14 |
| 